PIIIW Reconciled Depreciation from 2010 to 2025

PIIIW Stock  USD 0.02  0  17.02%   
P3 Health Reconciled Depreciation yearly trend continues to be fairly stable with very little volatility. Reconciled Depreciation is likely to outpace its year average in 2025. During the period from 2010 to 2025, P3 Health Reconciled Depreciation regression line of quarterly data had mean square error of 715.1 T and geometric mean of  2,099,486. View All Fundamentals
 
Reconciled Depreciation  
First Reported
2010-12-31
Previous Quarter
100.1 M
Current Value
105.1 M
Quarterly Volatility
44.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check P3 Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among P3 Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 104.7 M, Interest Expense of 17.5 M or Selling General Administrative of 133.7 M, as well as many indicators such as Price To Sales Ratio of 0.11, Dividend Yield of 0.0 or PTB Ratio of 0.96. PIIIW financial statements analysis is a perfect complement when working with P3 Health Valuation or Volatility modules.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Latest P3 Health's Reconciled Depreciation Growth Pattern

Below is the plot of the Reconciled Depreciation of P3 Health Partners over the last few years. It is P3 Health's Reconciled Depreciation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in P3 Health's overall financial position and show how it may be relating to other accounts over time.
Reconciled Depreciation10 Years Trend
Slightly volatile
   Reconciled Depreciation   
       Timeline  

PIIIW Reconciled Depreciation Regression Statistics

Arithmetic Mean29,443,687
Geometric Mean2,099,486
Coefficient Of Variation151.92
Mean Deviation39,950,805
Median342,196
Standard Deviation44,731,061
Sample Variance2000.9T
Range104.8M
R-Value0.82
Mean Square Error715.1T
R-Squared0.67
Significance0.0001
Slope7,669,958
Total Sum of Squares30013T

PIIIW Reconciled Depreciation History

2025105.1 M
2024100.1 M
202387 M
202187.3 M
2020795.2 K
2019399.2 K

About P3 Health Financial Statements

P3 Health investors use historical fundamental indicators, such as P3 Health's Reconciled Depreciation, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in P3 Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Reconciled Depreciation100.1 M105.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for PIIIW Stock Analysis

When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.